相关实验视频

Updated: Jun 11, 2025

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

重组Trichomonas vaginalis 20S蛋白酶与共价抑制剂结合的结构阐明

Jan Silhan¹, Pavla Fajtova^2,3, Jitka Bartosova¹

¹Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Prague, Czech Republic.

Nature communications

|October 4, 2024

概括

研究人员为药物开发开发开发了一种复合的Trichomonas vaginalis蛋白酶体 (Tv20S). 结构研究揭示了用于治疗常见的性传播疾病 - - 三虫病的特定抑制剂.

科学领域:

生物化学生物化学
结构生物学结构生物学
寄生虫学的寄生虫学

背景情况:

蛋白质体对细胞中的蛋白质平衡至关重要.
阴道 (Trichomonas vaginalis (Tv)) 蛋白质体是潜在的抗菌点.
原生电视保护体隔离挑战阻碍了研究.

研究的目的:

为了创建一个重组Tv 20S蛋白酶体 (Tv20S),用于结构和生化研究.
通过马里佐米布 (MZB) 和卡玛菲辛-17 (CP-17) 进行Tv20S抑制的特征.
为开发针对TV的特定抑制剂提供基础.

主要方法:

在昆虫细胞中,Tv20S子单元和Ump-1伴侣体的重组表达.
生物化学分析证实了重组Tv20S活动.
低温电子显微镜 (cryo-EM) 用于确定Tv20S-抑制剂复合结构.

主要成果:

重组Tv20S在生物化学上相当于原生蛋白酶体.
马里佐米布 (MZB) 抑制所有催化子单元,而CP-17则特别针对β2和β5.
低温EM结构揭示了抑制剂结合模式,并解释了差异性特异性.

结论:

一个重组的Tv20S系统促进了结构和生化研究.
CP-17对Tv20S的特异性高于MZB. CP-17对Tv20S的特异性高于MZB. CP-17对Tv20S的特异性高于MZB.
结构洞察力使得针对性抑制剂的设计能够用于三病治疗.

更多相关视频

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay

Published on: April 29, 2020

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

相关概念视频

The Proteasome Structure

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...